MassMutual Private Wealth & Trust FSB boosted its position in MetLife, Inc. (NYSE:MET – Free Report) by 11.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,605 shares of the financial services provider’s stock after purchasing an additional 263 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in MetLife were worth $213,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. Benjamin F. Edwards & Company Inc. lifted its position in MetLife by 2.0% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 11,297 shares of the financial services provider’s stock valued at $793,000 after acquiring an additional 220 shares during the last quarter. Sei Investments Co. increased its position in shares of MetLife by 20.3% during the second quarter. Sei Investments Co. now owns 411,610 shares of the financial services provider’s stock worth $28,888,000 after purchasing an additional 69,553 shares in the last quarter. ProShare Advisors LLC lifted its holdings in shares of MetLife by 0.5% during the 2nd quarter. ProShare Advisors LLC now owns 125,806 shares of the financial services provider’s stock valued at $8,830,000 after purchasing an additional 608 shares during the last quarter. Frank Rimerman Advisors LLC boosted its position in shares of MetLife by 4,706.4% in the 2nd quarter. Frank Rimerman Advisors LLC now owns 4,518 shares of the financial services provider’s stock worth $317,000 after purchasing an additional 4,424 shares in the last quarter. Finally, 1832 Asset Management L.P. increased its position in MetLife by 79.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,344 shares of the financial services provider’s stock valued at $94,000 after buying an additional 593 shares in the last quarter. 94.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages have weighed in on MET. TD Cowen raised their price target on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Jefferies Financial Group upped their price target on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research note on Friday, September 27th. Wells Fargo & Company lowered their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. Finally, Barclays upped their target price on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, January 6th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $89.92.
MetLife Stock Performance
NYSE MET opened at $85.78 on Thursday. The firm has a market capitalization of $59.39 billion, a P/E ratio of 17.29, a PEG ratio of 0.66 and a beta of 1.07. The stock has a 50-day simple moving average of $83.60 and a two-hundred day simple moving average of $79.78. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $89.05.
MetLife Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 2.54%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio is currently 43.95%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Oracle Announces Game-Changing News for the AI Industry
- Golden Cross Stocks: Pattern, Examples and Charts
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- CD Calculator: Certificate of Deposit Calculator
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.